Retour
67
Fourchette du Jour
73,68 €
75,09 €
Fourchette 52 Semaines
56,71 €
99,50 €
Volume
148 048
Moyenne 50J / 200J
78,57 €
/
80,76 €
Clôture Précédente
73,31 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 21,2 | 0,3 |
| P/B | 3,1 | 3,0 |
| ROE % | 16,2 | 3,7 |
| Net Margin % | 8,9 | 3,8 |
| Rev Growth 5Y % | 42,2 | 10,0 |
| D/E | 0,6 | 0,2 |
Objectif de Cours des Analystes
Hold
107,00 €
+44.5%
Low: 90,00 €
High: 124,00 €
P/E Prévisionnel
8,16
BPA Prévisionnel
9,05 €
Croissance BPA (est.)
+0,0%
CA Est.
1,09B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
13,45 €
12,71 € – 13,95 €
|
1,50B | 2 |
| FY2029 |
12,69 €
11,99 € – 13,16 €
|
1,37B | 2 |
| FY2028 |
12,46 €
11,78 € – 12,92 €
|
1,30B | 3 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
0,01%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 42,18% annually over 5 years — strong growth
ROE of 16,16% — decent returns on equity
Generating 171,39M in free cash flow
Cash machine — converts 218,79% of earnings into free cash flow
Capital efficient — spends only 1,57% of revenue on capex
Croissance
Revenue Growth (5Y)
42,18%
Revenue (1Y)43,78%
Earnings (1Y)N/A
FCF Growth (3Y)30,62%
Qualité
Return on Equity
16,16%
ROIC7,04%
Net Margin8,87%
Op. Margin9,20%
Sécurité
Debt / Equity
0,60
Current Ratio2,71
Interest Coverage4,05
Valorisation
P/E Ratio
21,23
Forward P/E8,16
P/B Ratio3,08
EV/EBITDA20,97
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 43,78% | Revenue Growth (3Y) | 34,71% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | 104,24% |
| Revenue Growth (5Y) | 42,18% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 883,37M | Net Income (TTM) | 78,34M |
| ROE | 16,16% | ROA | 5,44% |
| Gross Margin | 51,01% | Operating Margin | 9,20% |
| Net Margin | 8,87% | Free Cash Flow (TTM) | 171,39M |
| ROIC | 7,04% | FCF Growth (3Y) | 30,62% |
| Safety | |||
| Debt / Equity | 0,60 | Current Ratio | 2,71 |
| Interest Coverage | 4,05 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,01% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 21,23 | Forward P/E | 8,16 |
| P/B Ratio | 3,08 | P/S Ratio | 1,88 |
| PEG Ratio | -0,05 | Forward PEG | N/A |
| EV/EBITDA | 20,97 | Fwd EV/EBITDA | 3,79 |
| Forward P/S | 1,53 | Fwd Earnings Yield | 12,25% |
| FCF Yield | 10,30% | ||
| Market Cap | 1,66B | Enterprise Value | 1,70B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 883,37M | 614,38M | 486,82M | 316,39M | 216,14M |
| Net Income | 78,34M | -18,52M | 18,78M | -47,90M | -42,60M |
| EPS (Diluted) | 3,32 | -1,04 | 0,94 | -3,05 | -3,40 |
| Gross Profit | 450,64M | 364,17M | 305,30M | 177,60M | 115,53M |
| Operating Income | 81,23M | 584 000,0 | 46,97M | -35,28M | -39,79M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,44B | 1,28B | 904,42M | 760,09M | 771,60M |
| Total Liabilities | 899,65M | 855,17M | 446,82M | 421,55M | 412,86M |
| Shareholders' Equity | 540,72M | 428,53M | 457,60M | 338,54M | 358,74M |
| Total Debt | 325,20M | 624,09M | 285,67M | 286,52M | 287,37M |
| Cash & Equivalents | 285,59M | 144,86M | 221,12M | 48,23M | 100,30M |
| Current Assets | 753,12M | 527,68M | 519,82M | 344,26M | 321,78M |
| Current Liabilities | 278,11M | 193,68M | 145,48M | 99,44M | 87,54M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#124 of 1052
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026